The University of Chicago Header Logo

Connection

Olwen Hahn to Abiraterone Acetate

Back to Details
This is a "connection" page, showing publications Olwen Hahn has written about Abiraterone Acetate.
Olwen Hahn
Connection Strength
0.056
Abiraterone Acetate
  1. Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial). J Clin Oncol. 2023 06 20; 41(18):3352-3362.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.